Skip to content
★ Sign in to follow
WF

Wassim FARES

Bellerophon Therapeutics, Inc.
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€34k
▼ Sales (0 ops.)
—

Latest filing published 14 Sept 2020 for Bellerophon Therapeutics, Inc., €34k.

Filing timeline

BuySale
Wassim FARES

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Wassim FARES: trading record in brief

Our data holds just one disclosure by Wassim FARES, dated 14 September 2020, reporting an open-market purchase worth €34k in Bellerophon Therapeutics, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Wassim FARES

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief Medical OfficerExecutivesBellerophon Therapeutics, Inc.
    40,720 USD19SEC
    4,000 shares@ US$10.18100.0% of flowCommon StockSEC:0001600132-20-000089:0
    Canonical exit: 9 Dec 2020 (T+90)

1 of 1 declaration